Neurobrucellosis presenting as clinically definite amyotrophic lateral sclerosis

Int J Neurosci. 2018 Jul;128(7):686-688. doi: 10.1080/00207454.2017.1412968. Epub 2017 Dec 29.

Abstract

Purpose/Aim: We describe the first case of a patient with neurobrucellosis presenting with clinically-definite ALS.

Material and methods: A 48-year old male patient, in whom the diagnoses of systemic brucellosis and clinically definite ALS were undoubtedly confirmed and were eventually causally interrelated. The disease-specific antibiotic therapy was unsuccessful to slow the evolution of the motor neuron disease and the patient became non ambulatory over time.

Results: Considering the close temporal association of ALS onset with the systemic Brucella infection and consequent antigenic stimuli, we might suggest that human brucellosis might have triggered a process of motor neuron degeneration in keeping with neurobrucellosis, primarily due to parainfectious mechanism.

Conclusion: Our case helps to shed light on the factors that may trigger or only fasten motor neuron disease manifestations.

Keywords: ALS; brucellosis; degeneration; neurobrucellosis; parainfectious mechanism.

Publication types

  • Case Reports

MeSH terms

  • Amyotrophic Lateral Sclerosis / diagnosis*
  • Amyotrophic Lateral Sclerosis / etiology*
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Bacterial / metabolism
  • Brucella / immunology
  • Brucella / pathogenicity
  • Brucellosis / complications*
  • Brucellosis / drug therapy
  • Humans
  • Male

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial